Compared with EGF, EREG resulted in a weaker EGFR dimer with a shorter life span, which triggered aberrant EGFR signaling and sustained ERK pathways, leading to breast cancer cell differentiation [128]. The gene discussed is EGFR; the disease is breast carcinoma.